BioPharmX
CompanyUnited States
BioPharmX develops one asset, approved (minocycline in acne vulgaris). Mostly small molecule acting on inflammation; based in the United States.
- 1
- Asset
- Furthest
- Approved
- 3
- Trials
- 0
- Signals
Pipeline
1Tetracycline antibiotic inhibiting bacterial protein synthesis with anti-inflammatory and neuroprotective properties
Approved, Small molecule, Inflammation, acne vulgaris, Adult Periodontitis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials3
- Similar companies6
Updated 7 Oct 2026 · 29 sources